Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT02639793

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02639793
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Finland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02639793. Randomized; single masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)
Acronym
MRICEMAN
Intervention (Procedure)
catheter ablation
Lead sponsor
Heikki Huikuri (class: other)
Collaborator
University of Helsinki (class: other)

Record details

Record id
cardio:ct-nct02639793
Content hash
94b45f6e660a625f115c56d99be49b5022f7be4a0c4195627ac12048dde60909